NASDAQ:TORC
Delisted

Restorbio Stock News

etoro logo Buy TORC
*Your capital is at risk
$12.41
+0 (+0%)
At Close: Aug 17, 2022
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2026) - TinOne Resources Inc. (TSXV: TORC) (OTC Pink: TORCF) (FSE: 57Z) ("TinOne" or the "Company") announces that under the terms of the conve
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - TinOne Resources Inc. (TSXV: TORC) (OTCQB: TORCF) (FSE: 57Z) ("TinOne" or the "Company") announces that under the terms of the conve
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2025) - TinOne Resources Inc. (TSXV: TORC) (OTCQB: TORCF) (FSE: 57Z) ("TinOne" or the "Company") announces that the Company has closed its n

TinOne Upsizes Private Placement

03:04pm, Tuesday, 19'th Aug 2025
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - TinOne Resources Inc. (TSXV: TORC) (OTC Pink: TORCF) (FSE: 57Z) ("TinOne" or the "Company") announces that the Company has upsized its

TinOne Announces Re-Pricing of Private Placement

02:13pm, Wednesday, 30'th Jul 2025
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2025) - TinOne Resources Inc. (TSXV: TORC) (OTCQB: TORCF) (FSE: 57Z0) ("TinOne" or the "Company") announces that the Company has adjusted the pr
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - TinOne Resources Inc. (TSXV: TORC) (OTCQB: TORCF) ("TinOne" or the "Company") is pleased to announce it has completed the confirmator
Adicet: Promising 2021 Therapeutic Initiations, Cash Of $108 Million, And New Management
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rub
Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical develo
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or trea
TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, today announced a collaboration with resTORbio, Inc. (Nasdaq: TORC). r
BOSTON, July 28, 2020 (GLOBE NEWSWIRE) -- resTORbio resTORbio, Inc. (Nasdaq: TORC) today announced the award from the National Institute on Aging to fund a randomized, double-blind, placebo-controlled
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE